Ananda Pharma Plc (ANA) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Dec 2025 09:41 AM
RNS
Redemption of Unsecured CLNs and Director Dealing
03 Dec 2025 07:00 AM
RNS
CIPN Ethics Approval
27 Nov 2025 07:00 AM
RNS
Initial Data from Phase 1 Study
26 Nov 2025 07:00 AM
RNS
Posting of Q&A
24 Nov 2025 07:00 AM
RNS
Notice of General Meeting and Proposed Delisting
10 Nov 2025 07:00 AM
RNS
Confirmation of receipt of £168k R&D tax refund
13 Oct 2025 02:45 PM
RNS
Interims for the six months ended 31 July 2025
06 Oct 2025 07:00 AM
RNS
Ananda Hits Key Phase 1 Milestone for MRX1 CBD
26 Sep 2025 11:10 AM
RNS
Ananda ends UCL/GOSH trials, prioritises MRX1
16 Sep 2025 07:00 AM
RNS
Ananda attending Cannabinoid Summit
01 Sep 2025 07:00 AM
RNS
Ananda to attend Science in the City
26 Aug 2025 02:43 PM
RNS
Result of Annual General Meeting
19 Aug 2025 07:00 AM
RNS
Webinar Presentation Release
30 Jul 2025 01:49 PM
RNS
Notice of Annual General Meeting
30 Jul 2025 12:44 PM
RNS
Publication of Annual Report
15 Jul 2025 09:31 AM
RNS
First Participant Dosed in MRX1 CBD Phase 1 Study
01 Jul 2025 07:00 AM
RNS
MRX1 Delivered to Clinical Trial Site
23 Jun 2025 07:00 AM
RNS
Key Milestone in MRX1 Path to Clinical Trials
03 Jun 2025 07:00 AM
RNS
Publication of Phase 1 study on clinicaltrials.gov
02 Jun 2025 07:00 AM
RNS
MRX1 achieves 2 years of stability data
27 May 2025 07:00 AM
RNS
Ananda to attend Benzinga Conference
06 May 2025 07:00 AM
RNS
Appointment of Giles Moss as Advisor
28 Apr 2025 07:00 AM
RNS
TGA Receives Ananda’s Clinical Trial Notification
14 Apr 2025 07:00 AM
RNS
Ananda Pharma commences trading on OTCQB Exchange
08 Apr 2025 07:00 AM
RNS
Appointment of Chris Tovey, GW Pharma Former COO
02 Apr 2025 07:00 AM
RNS
MRX1 Granted Ethics Approval for Phase 1 Study
12 Mar 2025 07:00 AM
RNS
Master Investor Conference Attendance
04 Mar 2025 07:00 AM
RNS
Director/PDMR Shareholding
21 Feb 2025 07:00 AM
RNS
CEO Presenting at Private Investor Conference
20 Feb 2025 07:00 AM
RNS
Achievement of Manufacturing Milestone for MRX1
06 Feb 2025 03:06 PM
RNS
Director/PDMR Shareholding
06 Feb 2025 07:00 AM
RNS
Appointment of Commercial Adviser
03 Feb 2025 04:35 PM
RNS
Change of Registered Office
03 Feb 2025 07:00 AM
RNS
Ananda Pharma Appoints Viridian Capital Advisors
22 Jan 2025 07:00 AM
RNS
2025 Kick-Off Webinar
07 Jan 2025 11:34 AM
RNS
Total Voting Rights
20 Dec 2024 07:00 AM
RNS
Change of Name
11 Dec 2024 07:00 AM
RNS
Subscription to raise £150,000
09 Dec 2024 07:00 AM
RNS
Further Promising Results for MRX1
03 Dec 2024 07:00 AM
RNS
Key Stability Testing Milestones Achieved for MRX1
25 Nov 2024 12:00 PM
RNS
Publication of article in Leading Journal
12 Nov 2024 07:00 AM
RNS
Director Dealing
04 Nov 2024 07:00 AM
RNS
Presenting at Aquis Showcase
31 Oct 2024 07:00 AM
RNS
Total Voting Rights
30 Oct 2024 07:30 AM
RNS
Investor Meet Company Presentation
30 Oct 2024 07:00 AM
RNS
Interims for the six months ended 31 July 2024
21 Oct 2024 07:00 AM
RNS
Ananda Developments Epilepsy Trials
09 Oct 2024 07:00 AM
RNS
Phase 1 PK Study to be conducted on MRX1
08 Oct 2024 02:45 PM
RNS
Result of General Meeting
08 Oct 2024 10:50 AM
RNS
Change of Location for General Meeting
UK 100

Latest directors dealings